Layer 2 · AMAT — Applied Materials
Thesis
Record Q2, guide raised — but Tier B not Tier A because AMAT is less HBM-pure than LRCX or KLAC, and the China export overhang caps the multiple. The thesis works but the path to outperformance vs the WFE basket is less obvious than the pure HBM names.
What it does + financial print
AMAT is the broadest WFE vendor — deposition (Endura, Producer), etch (Sym3 Magnum), implant, CMP, ion-beam — supplying every major fab globally. AI tailwind hits AMAT through HBM packaging (through-silicon-via deposition, hybrid bonding tools), advanced logic (DRAM trench, gate-all-around finFET), and the new EUV-deposition Sciencia tool family.
Q2 FY26 (May 14) printed $7.91B revenue (record, +11.4% YoY) versus $7.69B consensus — a beat — and $2.86 EPS versus $2.68 (+6.7%). Q3 guide raised to EPS $3.36 ± $0.20 (above consensus $3.10). The fundamentals are clean.
Bull case
A specific HBM-tool design win disclosure — say, AMAT capturing the deposition pull on HBM4E ramp at SK Hynix or Samsung — re-rates AMAT closer to LRCX's multiple. China demand resilience continues (mature-node tools not yet under export control). Sciencia EUV-deposition lands a tier-1 customer.
Gap / bear case
The China export licence regime tightens under the Trump administration, hitting both DUV-adjacent tools and HBM-relevant deposition gear. Consensus already models 15% revenue growth — anything less will reset the multiple. AMAT's general-purpose exposure is a weakness in a market that rewards HBM/AI-purity.
Trigger to upgrade / downgrade
Upgrade to Tier A on an explicit HBM-tool win disclosure with named customer, OR a pullback to $390-410. Downgrade on China export rules expanding to AMAT's HBM-adjacent SKUs.
The trade
- Entry zone: $390-410 on pullback
- Stop: $370 close (200-day)
- Position size: 1.5% NLV
- Catalyst date: Q3 print August 14 2026
- Conviction: 6/10